Table 1.
Demographic and paraclinical data in the two groups of patients
| Parameter | Group -S (Patients with sepsis) (n=40, 54%) | Group- C(Control. Patients without sepsis) (n=34, 46%) | P value |
|---|---|---|---|
| Age (years, average ± SD) | 76 ± 15.87 | 68 ± 13.39 | 0.0525 |
| Gender, male (%) | 24 (60%) | 12 (35.29%) | 0.0393 |
| BMI (kg/m2, average ± SD) | 24.6 ± 8.34 | 26.9 ± 8.77 | 0.1300 |
| Days in intensive care unit TI (average ± SD) | 2 ± 4.6 | 10 ± 10.33 | < 0.0001 |
| Days under vasoactive treatment (average ± SD) | 1 ± 1.73 | 3 ± 3.35 | 0.0073 |
| Patients requiring vasoactive treatment (n, %) | 33 (82.5%) | 28 (82.23%) | 0.434 |
| Mortality (n, %) | 32 (80%) | 24 (70.59%) | 0.4197 |
| ANG-2 (ng/mL, average ± SD) | 7.37 ± 9.21 | 4.11 ± 4.34 | 0,0005 |
| PCT (ng/mL, average ± SD) | 1.525 ± 3.03 | 0.71 ± 0.75 | < 0.0001 |
| CRP (ng/mL, average± SD) | 164.4 ± 126.7 | 82.71 ± 78.98 | < 0.0001 |
| Haemoglobin (g/dL, average± SD) | 12.35 ± 3.09 | 11.75 ± 1.84 | 0.2762 |
| Haematocrit (%, average± SD) | 33.2 ± 8.99 | 34.05 ± 9.84 | 0.6879 |
| Leucocytes (x1000/mm3, average± SD) | 16.35 ± 12.44 | 13.95 ± 9.7 | 0.6027 |
| Creatinine (mg/dL, average± SD) | 1.84 ± 3.37 | 0.82 ± 1.88 | 0.0005 |
| Ureea (mg/dL, average± SD) | 104.9 ± 98.21 | 62.95 ± 58.68 | 0.0168 |
| APACHE II (val, average± SD) | 27 ± 8.8 | 23 ± 7.74 | 0.0152 |
| SOFA (val, average± SD) | 9 ± 3.65 | 7 ± 3.07 | 0.0616 |
| SAPS (val, average± SD) | 51.5 ± 20.18 | 42 ± 14.77 | 0.0276 |
∗
p value calculated using Mann-Whitney test (significant for p<0,05).